Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02924207 · ClinicalTrials.gov registry record · NA
Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes
A NA study, sponsored by St Elizabeth Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT02924207 is a NA study that has completed, run by St Elizabeth Healthcare. The registered enrollment target is 77 participants.
The verdict
NCT02924207, a NA study, has completed, sponsored by St Elizabeth Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
To determine the impact of an electronic decision support tool on physician decision making and patient outcomes for the treatment of poorly controlled diabetes mellitus. Primary endpoint will measure change in hemoglobin A1c. Secondary endpoints will examine cost of therapy and patient satisfaction with therapy. Study hypothesis is that use of the PATH decision tool will produce greater reduction overall in measurements of hemoglobin A1c in patients who participate and follow the PATH decision tool than patients who elect not to follow the PATH decision tool. PATH decision tool will provide more cost effective solutions for management of diabetic medication than current methods.
Interventions
- OTHER PATH electronic decision support tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02924207
The ClinicalTrials.gov registry entry for NCT02924207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St Elizabeth Healthcare, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PATH electronic decision support tool is the first listed.
NCT02924207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02924207 about?
NCT02924207 is a clinical study titled "Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes". To determine the impact of an electronic decision support tool on physician decision making and patient outcomes for the treatment of poorly controlled diabetes mellitus. Primary endpoint will measure change in hemoglobin A1c. Secondary endpoints will examine cost of therapy and patient satisfaction...
What is the current status of trial NCT02924207?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2016-09. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02924207?
The interventions under investigation include: PATH electronic decision support tool (OTHER).
Who is sponsoring clinical trial NCT02924207?
This trial is sponsored by St Elizabeth Healthcare, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.